Free Research Preview. DrugChatter may produce inaccurate information.
Ask Anything...
Profile for Biogen Inc. (BIIB)
« Back to company indexBIIB Chatter Timeline
Stock Ticker for BIIB
Most Active Tweeters for BIIB
No tweets foundRecent Tweets for BIIB
 |
@RandyGravity No action from Luke $GSK since Dec when he said he was on hunt for M&A. No action from Chris $BIIB since he joined… https://t.co/Uh6lyu0u4M April 18th 2023, 2:04am |
 |
@MichaelWalsted RT @MichaelWalstedt: $BIIB showing some nice accumulation patterns throughout this recent move. Certainly an RS leader since late September… April 18th 2023, 1:04am |
 |
@MarketCurrents $BIIB $LLY - Biogen upgraded to overweight at Piper Sandler on bullish Leqembi outlook https://t.co/stLp8iYzsO April 17th 2023, 8:04pm |
 |
@globalstockflsh Biogen $BIIB was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now… https://t.co/gIj02MzHQc April 17th 2023, 8:04pm |
 |
@WAM_Trader $BIIB Hit the profit target 8.60 April 17th 2023, 8:04pm |
 |
@LlcBillionaire Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst – Biogen (NASDAQ: $BIIB) https://t.co/eyhJi7UtYj April 17th 2023, 6:04pm |
 |
@bthefirsttoknow First out// $BIIB: Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst https://t.co/S6f7ng9HxB April 17th 2023, 6:04pm |
 |
@nicoleneverchas $BIIB Argus Research Maintains Buy on Biogen, Raises Price Target to $320 April 17th 2023, 3:04pm |
|
@bthefirsttoknow First out// $BIIB: Argus Research Maintains Buy on Biogen, Raises Price Target to $320 https://t.co/pM7u5nrXB0 April 17th 2023, 3:04pm |
 |
@schaeffers Biogen $BIIB earned two bull notes, roughly a week before the biotech giant is slated to report first-quarter… https://t.co/ewcPmn8pZz April 17th 2023, 2:04pm |
 |
@Honeystocks1 Biogen $BIIB Update. Target now met. https://t.co/JJ2Ld4cqdK https://t.co/tuy8yVEyJQ April 17th 2023, 2:04pm |
|
@MarketCurrents $BIIB $ESALF - Biogen's Leqembi has questionable efficacy, cost effectiveness, ICER says https://t.co/Dt5ZkcurgC April 17th 2023, 2:04pm |
 |
@MrBob55276379 $BIIB Top analyst price target for next week......?~~ https://t.co/EJwn9qwCs7 April 17th 2023, 1:04pm |
 |
@biobrainbox @Sports_bios The $BIIB/$IONS data is really interesting especially in the light of the failure of "1st generation"… https://t.co/jw5nujOOEj April 17th 2023, 1:04pm |
|
@WAM_Trader $BIIB CALLS R UP 100%, $MRK 25% April 17th 2023, 1:04pm |
 |
@InvestorsPrism [email protected] $BIIB Leqembi set-up and others ‘too good to ignore’ #stockstowatch #stocksinfocus #investors #daytrader… https://t.co/JTKKHZ7mft April 17th 2023, 12:04pm |
 |
@Street_Insider Biogen's $BIIB Leqembi set-up and others 'too good to ignore' https://t.co/OeF7Usxfzb https://t.co/dqAWv3Qon3 April 17th 2023, 12:04pm |
|
@nicoleneverchas $BIIB Wedbush Maintains Neutral on Biogen, Raises Price Target to $263 April 17th 2023, 12:04pm |
|
@bthefirsttoknow First out// $BIIB: Wedbush Maintains Neutral on Biogen, Raises Price Target to $263 https://t.co/EtwKT334f4 April 17th 2023, 12:04pm |
 |
@mediasentiment $BIIB new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 112 April 17th 2023, 11:04am |
|
@mediasentiment $BIIB new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 111 April 17th 2023, 11:04am |
 |
@thudderwicks $BIIB upgraded to Overweight from Neutral at Piper Sandler April 17th 2023, 11:04am |
 |
@BankTheTrade $BIIB(288.13) up 3.70 thinnn Piper Sandler analyst Christopher Raymond upgrades Biogen (NASDAQ:BIIB) from Ne… https://t.co/MfAYAPQclQ April 17th 2023, 10:04am |
|
@mediasentiment $BIIB new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 58 April 17th 2023, 10:04am |
 |
@theflynews Biogen upgraded to Overweight from Neutral at Piper Sandler $BIIB https://t.co/Xz3PYMYTvM April 17th 2023, 10:04am |
 |
@semodough Piper $BIIB Raising Leqembi estimates and our price target and rating on BIIB shares, now buyers to the mid $340s b… https://t.co/P2EeSPzTRL April 17th 2023, 10:04am |
|
@mediasentiment $BIIB new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 54 April 17th 2023, 10:04am |
 |
@BioStocks $BIIB upgraded to Overweight at Piper. PT $346 April 17th 2023, 10:04am |
 |
@anachartanalyst #PIPERSANDLER analyst Christopher Raymond who covers $BIIB has the current 1st biggest #pricetarget movement by upg… https://t.co/1HMiuzpLPT April 17th 2023, 10:04am |
|
@mediasentiment $BIIB new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 49 April 17th 2023, 9:04am |
 |
@SwatOptions $BIIB Upgraded to Overweight with $346 Price Target at Piper Sandler April 17th 2023, 9:04am |
 |
@UsMarketNews $BIIB positive Piper Sandler Upgrades Biogen to Overweight, Raises Price Target to $346 April 17th 2023, 9:04am |
|
@bthefirsttoknow First out// $BIIB: Piper Sandler Upgrades Biogen to Overweight, Raises Price Target to $346 https://t.co/jfSyUeQUCS April 17th 2023, 9:04am |
|
@bthefirsttoknow First out// $BIIB: Biogen Earnings Conference Call Is Coming Up, Here's What You Need To Know https://t.co/fc8lZrAs8b April 17th 2023, 7:04am |
 |
@Tickeron What is the difference between $BIIB and $TGTX? Learn it. #Biogen https://t.co/3ymVSFdyDU https://t.co/AkZLBsqO8L April 17th 2023, 3:04am |
 |
@SmashTheBidd RT @psk2329: Despite Failed Phase 3 Study, FDA Staff Says Biogens ALS Drug May Have Clinical Benefit $BIIB April 16th 2023, 10:04pm |
 |
@Milchiggggs @Comedyorwat how about $biib April 16th 2023, 8:04pm |
 |
@Julia700161 $BIIB Top analyst price target for next week>?? https://t.co/3Ek8QHQ7uP April 16th 2023, 5:04pm |
 |
@optioncharts $BIIB Delta expiration 04/21/2023 #maxpain #options https://t.co/ZIh6T3TXhC https://t.co/NmF0GBfJ1c April 16th 2023, 3:04pm |
 |
@Loretta36000494 $BIIB Real time stock analyses ratings and target your Prices, https://t.co/Wmy0krn6xq April 16th 2023, 2:04pm |
 |
@OptionsMike $BIIB Nicely holding the downtrend break. Over 293 can run https://t.co/vryTIz1xZ3 April 16th 2023, 1:04pm |
 |
@Sir_PeteShiffy $BIIB stop loss moved up, let her rip. https://t.co/7qD7veGVpY https://t.co/snDQJAT16C April 16th 2023, 11:04am |
 |
@Sophia96180515 $BIIB Top analyst price target for next week.. :?>??>?~~ https://t.co/og0IqhFFAs April 16th 2023, 5:04am |
|
@Julia700161 $BIIB Top analyst price target for next week.. :?>??>?~~ https://t.co/3Ek8QHQ7uP April 16th 2023, 4:04am |
 |
@Chloet59289379 $biib top analyst price target for next week https://t.co/vGuDm0WjWc April 16th 2023, 2:04am |
 |
@alerts_flash $BIIB Top analyst price target for next week.......>? https://t.co/KtniMl2og4 April 16th 2023, 1:04am |
 |
@MysteriousMole1 $BIIB $DNLI converging on MAPT https://t.co/lnPOKvQOz2 https://t.co/3ynUqF9cKw April 15th 2023, 11:04am |
 |
@Jard31003731 $biib *Top analyst price target for next week ??? https://t.co/6SZfX1G9EN April 15th 2023, 5:04am |
 |
@davil47222504 $biib *Top analyst price target for next week ??? https://t.co/pq6giVkglu April 15th 2023, 2:04am |
 |
@dailycandlestix $BIIB Below Avg Volume Daily appearances since 2010: 163 Close 5 days later ±: Avg: -0.97 SD: 11.11 Worst: -80.31 B… https://t.co/iozb5lwPiP April 14th 2023, 8:04pm |
DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC
2004 - 2023. All rights reserved.